BICSTaR suggests efficacy of start/switch to bictegravir/emtricitabine/TAF in PLHIV

Initiation or switch to the single-tablet regimen of bictegravir/emtricitabine/tenofovir alafenamide (TAF) led to low HIV-1 RNA viral load in people living with HIV (PLHIV), according to the BICSTaR study presented at HIV Glasgow 2020.

Rosacea linked to hypertension, dyslipidaemia
Rosacea, a chronic inflammatory cutaneous disorder associated with multiple systemic illnesses, is associated with hypertension and dyslipidaemia but not with ischaemic heart disease (IHD), stroke, or diabetes, results of a systematic review and meta-analysis have shown.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in